Contract development and manufacturing organizations signs 10-year lease for 68,000-square-foot clinical manufacturing facility
JLL completed a new lease transaction for WuXi Biologics at 7 Clarke Drive, Cranbury, N.J., with building owner Cedar Brook Corporate Center. The global company with leading open-access biologics technology platforms signed a lease for the entire 68,000-square-foot clinical manufacturing facility.
WuXi Biologics was represented by Robert Ryan and John Buckley, both executive vice presidents with JLL.
“WuXi Biologics continues to develop its global supply chain network,” said Ryan. “The Cranbury location offers the leading global CDMO tremendous access to New Jersey’s highly trained workforce and leading scientists’ pool.”
WuXi Biologics inked a 10-year lease for the entire 7 Clarke Drive in Cranbury, N.J. The facility comprises 68,000 square feet of research and development laboratory, biologics manufacturing, and office space. The tenant will equip the building with process development and quality control laboratories and other supporting functions.
This is the third location for the company in the United States. WuXi Biologics is building a new facility in Worcester, Mass., in addition to completing a lease of 33,000 square feet for a development laboratory in King of Prussia, Pa.
The 7 Clarke Drive clinical manufacturing facility was constructed in 1998 and is located within Cedar Brook Corporate Center, a 1.2 million-square-foot office and technology park on 150 acres in Cranbury. The property is conveniently located off Route 130, and in close proximity to the New Jersey Turnpike at Interchange 8A.
The property is a short distance from the Princeton Route 1 corridor, downtown Princeton and Princeton University, and a wide variety of stores, restaurants, hotels, theatres and cultural resources.
JLL is a leader in the northern/central New Jersey commercial real estate market, with more than 1,260 professionals and support staff providing agency leasing and property marketing, tenant representation, industrial services, strategic consulting, occupancy planning, workplace strategies, project and development services, property and facility management, and investment sales/capital markets debt and equity services to New Jersey's leading corporate tenants, investors and landlords. The firm, which assists clients from five full-service offices in Parsippany, Iselin (Metropark), Princeton, Morristown and East Rutherford, also acts as a local service provider for JLL’s global and national corporate clients in need of real estate assistance in New Jersey. NJBiz ranked JLL’s New Jersey operations as the No. 1 commercial real estate brokerage in the Garden State in 2020.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2019, there were a total of 250 integrated projects, including 121 projects in pre-clinical development stage, 112 projects in early-phase (phase I and II) clinical development, 16 projects in late-phase (phase III) development and one project in commercial manufacturing. With total estimated capacity for biopharmaceutical production planned in China, Ireland, the U.S., Germany and Singapore exceeding 280,000 liters by 2022, we will provide our biomanufacturing partners with a robust and premier-quality global supply chain network. For more information on WuXi Biologics, please visit www.wuxibiologics.com
About JLL
JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $18.0 billion, operations in over 80 countries and a global workforce of more than 94,000 as of March 31, 2020. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.
